NASDAQ:MAZE | Income Statement | Maze Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2024-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$34.94M$48.04M-$48.04M-$44.73M-$0.76-$0.7658,995,93458,995,934
2026-03-31$20M$34.15M$46.55M-$26.55M-$24.21M-$0.45-$0.4553,897,21653,897,216
2025-12-31$27.57M$38.06M-$38.06M-$34.57M$0.00-$34.57M-$0.60-$0.603,511,3903,511,390
2025-09-30$25.19M$32.97M-$32.97M-$30.09M$0.00-$30.09M-$0.66-$0.6645,779,57745,779,577
2025-06-30$0.00$28.11M$36.47M-$36.47M-$33.68M$0.00-$33.68M-$0.77-$0.7743,797,42143,797,421
2025-03-31$27.58M$35.4M-$35.4M-$32.79M-$32.79M-$1.15-$1.1528,628,43028,628,430
2024-12-31$0.00$22.22M$29.73M-$29.73M-$29.85M-$275,000.00-$29.58M-$2.07-$1.4211,977-656,867
2024-09-30$2.5M$19.86M$26.73M-$24.23M-$25.03M-$279,000.00-$24.75M-$10.25-$10.252,415,8972,415,897
2024-06-30$165M$19.55M$25.45M$139.56M$140.78M$1.73M$139.06M$5.92$3.222,389,1194,314,359
2024-03-31$21.88M$28.01M-$28.01M-$32.49M-$32.49M-$13.91-$13.912,336,6132,336,613

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$108.45M$142.9M-$142.9M-$131.12M$0.00-$131.12M-$3.05-$3.0542,976,02442,976,024
2024-12-31$167.5M$83.5M$109.91M$57.59M$53.4M$1.17M$52.23M$1.42$1.252,396,0942,730,299